Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Metagenomic Sequencing Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents and Consumables, Instruments, Sequencing Services, Analysis and Data Interpretation Solutions), By Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), By Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Meta transcriptomics), By Type (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental, Veterinary, Others), by Country, Segment, and Companies, 2024-2032
... Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Meta transcriptomics), By Type (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental, Veterinary, Others), by Country, Segment, and Companies, 2024-2032 The ... Read More
-
Non alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Therapeutics (Elafibranor, Ocaliva, Selonsertib, Cenicriviroc), Diagnostics (Imaging Techniques, Diagnostic Tests, Biopsy)), by Country, Segment, and Companies, 2024-2032
... Steatohepatitis Therapeutics and Diagnostics market size is poised to register 22.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Non alcoholic Steatohepatitis ... Read More
-
Biopreservation Market Size, Trends, Analysis, and Outlook By Product (Equipment, Media, Laboratory Information Management System (LIMS)), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), by Country, Segment, and Companies, 2024-2032
... poised to register 21.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biopreservation market across By Product (Equipment, Media, Laboratory Information Management ... Read More
-
Spatial Genomics and Transcriptomics Market Size, Trends, Analysis, and Outlook By Technique (Spatial Transcriptomics, Spatial Genomics Analysis), By Product (Instruments, Consumables, Software), By Application (Translational Research, Drug Discovery and Development), By End-User (Academic and Research Institutes, Contract Research Organization, Pharmaceutical and Biotechnology Companies), by Country, Segment, and Companies, 2024-2032
... Institutes, Contract Research Organization, Pharmaceutical and Biotechnology Companies), by Country, Segment, and Companies, 2024-2032 The global Spatial Genomics and Transcriptomics market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth ... Read More
-
Live Cell Imaging Market Size, Trends, Analysis, and Outlook By Products and Services (Instruments, Consumables, Software, Services ), By Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), By Technology (Time-Lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High Content Screening (HCS), Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032
... Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High Content Screening (HCS), Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032 The global Live Cell Imaging ... Read More
-
RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
... End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032 The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Next Generation Sequencing Market Size, Trends, Analysis, and Outlook By Product (NGS Consumables, Sequencing Services, Presequencing Products & Services, NGS Platforms, Bioinformatics, Management & Cloud Computing Solutions, Services for NGS Platforms), By Technology (Sequencing By Synthesis (ION Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Others), By Application (Diagnostics, Drug Discovery & Development, Agricultural & Animal Research, Others), By End-User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Reference Laboratories, Others), by Country, Segment, and Companies, 2024-2032
... Synthesis (ION Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Others), By Application (Diagnostics, Drug Discovery & Development, Agricultural & Animal Research, Others), By End-User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & ... Read More
-
Cattle Health Market Size, Trends, Analysis, and Outlook By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, Others), By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, Others), by Country, Segment, and Companies, 2024-2032
... global Cattle Health market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cattle Health market across ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Global Hyperkalemia Drugs Market - 2024-2031
... period 2024-2031. Hyperkalemia is a condition with too much potassium in the blood above the average level. Hyperkalemia happens if the kidneys do not work well which leads to life-threatening heart rhythm changes or cardiac ... Read More
-
AI In Genomics Market Size, Trends, Analysis, and Outlook By Offering (Software, Services), By Technology (Machine Learning, Others), By Function (Genome Sequencing, Gene Editing, Clinical Workflows, Predictive Genetic Testing & Preventive Medicine), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Others), By End-User (Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes, Government Organizations, Others), by Country, Segment, and Companies, 2024-2032
... Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Others), By End-User (Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes, Government Organizations, Others), by Country, Segment, and Companies, 2024-2032 The global AI ... Read More
-
Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029). The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the ... Read More
-
Small Molecule Drug Discovery Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others), By Process (Target ID/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization), by Country, Segment, and Companies, 2024-2032
... by Country, Segment, and Companies, 2024-2032 The global Small Molecule Drug Discovery market size is poised to register 8.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
New Drug Approvals and Their Contract Manufacture - 2024 Edition
... performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Scorecard) is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition ... Read More
-
Bioinformatics Services Market Size, Trends, Analysis, and Outlook By Application (Genomics, Chemoinformatics, Proteomics, Transcriptomics, Metabolomics, Others), By Type (Sequencing Services, Data Analysis, Drug Discovery Services, Differential Gene Expression Analysis, Database and Management Services, Others), By Industry (Medical, Animal, Plant, Environmental, Forensic), By End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, CROs, Others), by Country, Segment, and Companies, 2024-2032
... Industry (Medical, Animal, Plant, Environmental, Forensic), By End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, CROs, Others), by Country, Segment, and Companies, 2024-2032 The global Bioinformatics Services market size is ... Read More
-
Acne Vulgaris (AV) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AV. Topical retinoids and topical antibiotics are usually the first-line therapy for mild-to-moderate acne. The R&D activity is moderate within the AV space, ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Anti-obesity Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Prevalence of Obesity Over the past few decades, obesity ... Read More
-
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
... industry and its inherent dynamics. It provides valuable insights for firms interested in diversifying across various sectors or expanding their current activities into new geographical areas. Rise in IBD Incidence to Boost the Demand of ... Read More
-
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. ... Read More
-
Metabolomics Market Report by Product (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Others), and Region 2024-2032
... and Region 2024-2032 The global metabolomics market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% ... Read More
-
Human Growth Hormone Market Report by Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Small for Gestational Age, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), and Region 2024-2032
... Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), and Region 2024-2032 The global human growth hormone market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 ... Read More
-
Duchenne Muscular Dystrophy Drugs Market by Product Type (Corticosteroids, Pain Management Drugs), Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy), End User (Hospitals, Clinics, Home Care Settings), and Region 2024-2032
... drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.96% during 2024-2032. The rising prevalence ... Read More